2025-12-20 - Analysis Report
Okay, here's a breakdown of the Procter & Gamble (PG) stock data you provided, with simple numbers and analysis, followed by a comprehensive summary:

**1) Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that provides branded consumer packaged goods.
*   **PG Cumulative Return:** 26.13%
*   **VOO Cumulative Return:** 100.88%
*   **Divergence:** -73.0 (Relative Divergence: 7.0)

**Analysis:** PG has significantly underperformed the S&P 500 over the analyzed period.  The divergence of -73.0 indicates a substantial difference in cumulative returns. The relative divergence of 7.0 indicates PG is performing near the bottom of its divergence range compared to VOO historically.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%   | 0.0   | 215.0  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%   | 0.1   | 215.1  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%    | 0.3   | 292.3  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%    | 0.4   | 325.7  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%   | 0.5   | 382.9  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%   | 0.6   | 354.7  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%   | 0.4   | 343.0  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%  | 0.4   | 392.4  |
| 2023-2025  | -18.0%  | 80.1%   | -83.0%  | 0.1   | 338.1  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows fluctuating performance, with a significant drop in the 2023-2025 period.
*   **MDD:** The Maximum Drawdown is relatively high in recent periods, indicating significant potential losses.
*   **Alpha:** Alpha is mostly negative, indicating underperformance compared to its benchmark, with a very large negative value in the 2023-2025 period.  Positive Alpha indicates outperformance.
*   **Beta:** Beta values are low, indicating PG is less volatile than the overall market (S&P 500).

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 144.46
*   **Last Market Data:** Price 144.46, Previous Close 145.52, Change -0.73
*   **5-day SMA:** 145.63
*   **20-day SMA:** 144.91
*   **60-day SMA:** 148.06

**Analysis:**  The stock price is currently below both the 5-day and 20-day Simple Moving Averages, but above the 60-day SMA.  The negative change from the previous close indicates a slight downward trend.

**3) Indicators**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI:** 47.18 (Neutral)
*   **PPO:** 0.33
*   **Hybrid Signal:**  Buy 100% of cash (7 shares - Very Safe - MRI:0.90). Invest 0.8% of total investment ($1,000.00) monthly.
*   **Recent Divergence Change (20 days):** 5.8 (+) - Short-term Increase
*   **Expected Return:** 2.2% (Long-term)

**Analysis:**

*   The MRI suggests a medium investment recommendation.
*   The RSI is neutral, not indicating overbought or oversold conditions.
*   The positive divergence change suggests a recent upward movement in the stock's relative performance.
*   The Expected Return of 2.2% is modest but positive.

**4) Recent News & Significant Events**

*   **Buy PG Stock Over Colgate-Palmolive?** (Forbes)
*   **KMB vs. PG: Which Consumer Staples Stock Offers Better Upside Now?** (Zacks)
*   **Jim Cramer identifies his favorite portfolio stock — and it’s not a big tech name** (CNBC) - Potentially discusses PG.
*   **Shares of P&G Struggled in 2025. What Will It Do in 2026?** (Motley Fool)
*   **Procter & Gamble shares rise for seven consecutive sessions (NYSE:PG)** (Seeking Alpha)
*   **Aging Demographics Casts Shadow Over Dividend Growth at Procter & Gamble (PG)** (TipRanks)

**Analysis:**  The news is mixed.  Some articles suggest potential upside and favor PG over competitors, while others highlight struggles in 2025 and potential headwinds from demographic changes.  The headline about rising shares is positive.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~1.92)
*   **Target Price:** 168.95 (Avg), 186.00 (High), 148.00 (Low)
*   **Recent Rating Changes:** No changes provided.

**Analysis:** Analysts, on average, have a "Buy" rating for PG, and the average target price is significantly above the current price, indicating potential upside.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-24 | 2    | 22.39 B$   |
| 2025-04-24 | 1.58 | 19.78 B$   |
| 2025-01-22 | 1.94 | 21.88 B$   |
| 2024-10-18 | 1.65 | 21.74 B$   |
| 2025-10-24 | 1.65 | 21.74 B$   |

**Analysis:**  Earnings per share (EPS) and revenue have fluctuated.  The most recent quarter (2025-10-24) shows strong EPS and revenue. The duplicate entry of 2025-10-24 / 1.65 is likely a data error.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B   | 51.37%        |
| 2025-06-30   | $20.89B   | 49.11%        |
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |

**Analysis:** Revenue has generally been trending upwards over the last year, with the most recent quarter showing the highest revenue. Profit margins have remained relatively stable, fluctuating between 49% and 52%.

**Capital and Profitability:**

| Quarter      | Equity      | ROE    |
|--------------|-------------|--------|
| 2025-09-30   | $53.27B    | 8.92%  |
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |

**Analysis:** Equity has been increasing over the past year. Return on Equity (ROE) has fluctuated, indicating changes in profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary)**

**Overall Assessment:**

Procter & Gamble (PG) presents a mixed picture. While it's a large, established company with a strong brand portfolio and analyst consensus is positive, its recent performance has lagged the S&P 500 significantly. Recent news articles highlight both potential upside and challenges. Financials show steady revenue and healthy profit margins and increased equity. The MRI suggests a medium investment risk.

**Key Considerations:**

*   **Underperformance:**  The significant underperformance compared to the S&P 500 is a major concern.
*   **Mixed News:** The news headlines present both positive and negative catalysts, requiring careful evaluation.
*   **Analyst Optimism:** Analysts' "Buy" rating and target prices suggest potential for future gains.
*   **Financial Stability:** PG demonstrates financial stability with consistent revenue and healthy profit margins.
*   **Recent Uptick**: The short-term divergence and price increase could be a sign of recovery.
*   **Aging Demographics**: Consider the potential impact of aging demographics on dividend growth.

**Investment Recommendation (Based on data provided):**

Given the mixed data, a cautious approach is warranted. While analysts are optimistic, the underperformance and mixed news suggest careful consideration. The Hybrid Signal suggests a small initial investment followed by a monthly investment. It may be prudent to start with a smaller position and monitor the company's performance and the broader economic outlook before increasing exposure.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.